A股異動 | 掌閲科技(603533.SH)三連板 獲字節跳動11億入股
格隆匯11月9日丨掌閲科技(603533.SH)連續3個交易日漲停,現報36.74元,封單近20萬手,暫成交3958萬元,最新總市值147億元,該股今年迄今已累漲超1.1倍。掌閲科技上週三(4日)晚間發公告稱,字節跳動旗下量子躍動擬向公司控股股東受讓公司4505萬股,佔公司總股本的11.23%,量子躍動將成為公司第三大股東。本次股份轉讓價格確定為24.42元/股,股份轉讓價款總額為11億元。公司6日晚間再發公告稱,公司當前尚未開展具體深化合作事宜,未來推進進度存在不確定性。同時,相關實際業務開展狀況受到市場等多方面綜合因素影響,對公司當期及未來業績的影響程度存在一定不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.